# Wilson H. Miller

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/wilson-h-miller/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,507 |
| Field | Retinoids in leukemia and cellular processes |
| h-index | 81 |
| i10-index | 250 |
| Last Known Institution | Boone Hospital Center |
| OpenAlex ID | https://openalex.org/A5048013287 |
| ORCID iD | https://orcid.org/0000-0002-7408-1574 |
| Works | 624 |

## Researcher papers

- [Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma](https://scholariq.org/papers/ipilimumab-plus-dacarbazine-for-previously-untreated-metastatic-melanoma/)
- [Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/nivolumab-versus-chemotherapy-in-patients-with-advanced-melanoma-who-progressed/)
- [Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/avelumab-plus-axitinib-versus-sunitinib-for-advanced-renal-cell-carcinoma/)
- [Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial](https://scholariq.org/papers/genomic-and-transcriptomic-profiling-expands-precision-cancer-medicine-the/)
- [Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study](https://scholariq.org/papers/pembrolizumab-in-patients-with-microsatellite-instability-high-advanced/)
- [Systemic cancer therapy: achievements and challenges that lie ahead](https://scholariq.org/papers/systemic-cancer-therapy-achievements-and-challenges-that-lie-ahead/)

## Researcher topics

- [Retinoids in leukemia and cellular processes](https://scholariq.org/topics/retinoids-in-leukemia-and-cellular-processes/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Researcher university

- [Boone Hospital Center](https://scholariq.org/institutions/boone-hospital-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.